Headline
The latest stories from AHA Today.
At a Senate Health, Education, Labor and Pensions Committee hearing on his nomination to serve as Health and Human Services Secretary, Xavier Becerra said he supports additional COVID-19 funding for health care providers.
During an AHA virtual briefing for lawmakers and staff, leaders from three health systems — One Brooklyn Health System, Grady Health System, and The Hospitals of Providence, part of Tenet Healthcare — discussed the impact the COVID-19 pandemic is having on communities of color and how their health…
Hundreds of hospital and health system leaders today participated in an AHA advocacy virtual event to get the latest on Congress’ efforts to pass President Biden’s $1.9 trillion COVID-19 relief package and urge lawmakers to include provisions to support hospitals and health systems.
A new Kaufman Hall study is showing the extent to which hospitals’ finances continue to be negatively impacted by the COVID-19 pandemic.
In response to the Texas storm emergency, the Centers for Medicare & Medicaid Services announced further flexibilities for Texas health care facilities in addition to the existing pandemic waivers.
A new resource from the American Society for Health Care Engineering and Naval Medicine Readiness and Training Command summarizes recommended ventilation system controls for health care facilities treating COVID-19 patients.
Strategic alliances forged by AHA with organizations like the National Urban League and UnidosUS are strengthening collective effort to address well-documented, disparate health outcome for Black and Latino communities, writes Joy Lewis, AHA’s senior vice president for health equity strategies.
AHA urged the Department of Health and Human Services to make the process for hospitals to report data to the HHS TeleTracking COVID-19 Portal and other data reporting platforms as efficient, transparent and valuable as possible.
Authorized health care providers should now order the monoclonal antibody therapy bamlanivimab and antibody cocktail casirivimab/imdevimab directly from the sole distributor, AmerisourceBergen Corp., the Department of Health and Human Services announced.
The AHA, American Medical Association and American Nurses Association released a joint statement as the number of U.S. deaths related to COVID-19 approached 500,000.